WINNER: Cross-Provider Data Analysis to Drive National, Regional and Service-Level Prioritisation of Hepatitis C Elimination Efforts Across Drug Treatment Services: Gilead Sciences, CGL, Forward Trust, Humankind, NHS APA, Turning Point, WDP, We Are With You, NHS England, and the Hepatitis C Trust

As part of hepatitis C virus (HCV) elimination efforts and commitments made under the NHSE HCV Elimination tender, Gilead Sciences collect aggregated HCV testing, referral, and treatment commencement data from the largest drug treatment service providers in England (covering 144,000 clients) and format them into functional visual dashboards. This combined view of the DTS HCV pathway at national, regional, and service level supports effective partnership work with relevant stakeholders to prioritise, agree action, and evaluate the impact for a group of often marginalised and underserved patients and measures progression towards elimination of the virus across DTS in line with NHSE elimination goals. Judges said this was an inspirational project to hear about with clear need, high ambition, and great outcomes for the patient.


  • Actionable Insights - Health Inequalities Tool: CF and NHSE

  • Informatics-Led Patient Flow Management: Changeology.Group and Blackpool Teaching Hospitals FT

  • Co-Development of the A&E Admissions Forecasting Tool: Faculty and NHSE

  • Shared Healthcare Analytics Platform Reduces Cost and Accelerates Insight to Improve Hospital Services and Patient Journeys: Northdoor and Maidstone and Tunbridge Wells Trust

  • Population Health Management Development Programme: Optum and NHSE

HSJ Partnership Awards 2023 winners revealed